Pharmacist-guided PEP/PrEP Access Using PEPPI Software
Official title: Impact of PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
Run by Empowerx INC · NCT07683117 · Data updated 2026-11-12
This trial tests whether the PEPPI software helps pharmacists provide PEP/PrEP and helps patients access these HIV prevention options.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 195 (estimated) |
| Sponsor | Empowerx INC Academic / other |
| Locations | 1 site (Del Mar, California) |
| Status | Recruiting |
| Started | August 2026 |
| Main results expected | August 2028 |
| Study ends | September 2028 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT07683117 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pharmacists who provide or are willing to provide PEP/PrEP services at participating pharmacies, and patients 18 years or older seeking PEP or PrEP at those pharmacies.
✕Probably not a fit
Patients who do not use the software or whose pharmacies do not participate may not experience improved access.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares pharmacist implementation of PEP/PrEP services with and without the PEPPI software to see if the tool improves service delivery and patient access. Participants include licensed pharmacists who provide PEP/PrEP services and patients seeking PEP or PrEP at participating pharmacies. Pharmacists will use the PEPPI software as part of routine service delivery, while patient interactions will occur at pharmacies offering PEP/PrEP under the software protocol. The study seeks to quantify changes in ease of service provision and in patient access when the software is used. Lead sponsor is EMPOWERX Inc in collaboration with NIMH, with study sites in Del Mar, California.
Why it matters
Potential benefit: If successful, the software could make it easier for pharmacists to offer PEP/PrEP and help more people access HIV prevention.
How similar studies have gone: Previous work in digital tools for expanding pharmacist services has shown promise, but this exact PEPPI approach is being tested for its impact on both provider workflows and patient access.
Who can join: the full rules
Show full inclusion / exclusion criteria
PHARMACIST Participants Inclusion Criteria: * 18 years of age or older * Provide, or willing to provide, PEP/PrEP services in a participating pharmacy * Use the PEPPI software to provide birth control services Exclusion Criteria: * None PATIENT Participants Inclusion Criteria: * 18 years of age or older * Seek PEP or PrEP services at a participating pharmacy * Use the PEPPI software to receive PEP/PrEP services at a participating pharmacy Exclusion Criteria: * NONE
Where it's running
-
EmpoweRx, Inc
Del Mar, California, United States Recruiting
Study contacts
- Study coordinator: Jenny L Newlon, PharmD, PhD
- Email: jenny@birthcontrolpharmacist.com
- Phone: 8584120984
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Boosting long-acting injectable PrEP use among Latine gay/bisexual men and transgender women in the South
This project will try giving long-acting injectable PrEP (lenacapavir) through a community clinic to Latine gay and bisexual men and transgender women in Durham to see if people stay on PrEP longer.
-
Pharmacists using HAPPI software to make birth control easier to get
This project will test whether the HAPPI software helps pharmacists provide birth control more easily and helps patients access birth control at participating pharmacies.
-
Feasibility of Online HIV Prevention Research for People Who Inject Drugs
This study tests whether online recruitment and at-home HIV testing can be done reliably by and for people who inject drugs.
-
Host-led harm reduction for men who have sex with men who engage in chemsex in Bangkok
This project will try a host-led harm reduction approach to reduce substance-related, sexual, mental health, and legal harms among men who have sex with men who engage in chemsex in Bangkok.
-
Transgender-tailored harm reduction and PrEP service for people who engage in chemsex in Bangkok
This project will try a comprehensive harm-reduction service tailored for transgender and non-binary adults in Bangkok who engage in chemsex or substance use to increase PrEP use, reduce HIV/STIs, and address mental health and socio-legal needs.
-
See if PrEP Choice helps young people start and stick with HIV prevention methods
This trial tests whether the PrEP Choice package helps 13-24 year-olds in the U.S. begin and continue using PrEP or DoxyPEP for HIV prevention.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.